warfarin and Malabsorption-Syndromes

warfarin has been researched along with Malabsorption-Syndromes* in 5 studies

Reviews

1 review(s) available for warfarin and Malabsorption-Syndromes

ArticleYear
Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man.
    Vitamins and hormones, 1974, Volume: 32

    Topics: Adult; Alkylation; Biological Transport; Celiac Disease; Cholestasis; Dietary Fats; Feces; Humans; Infant; Intestinal Absorption; Intestines; Lipid Metabolism; Malabsorption Syndromes; Oxides; Pancreatitis; Tritium; Vitamin K; Vitamin K 1; Warfarin

1974

Other Studies

4 other study(ies) available for warfarin and Malabsorption-Syndromes

ArticleYear
Malabsorption-associated warfarin resistance.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009, Sep-01, Volume: 66, Issue:17

    A case of malabsorption- associated warfarin resistance is reported.. A 42-year-old, 111-kg, Caucasian man arrived at the emergency department with atypical pleuritic chest pain. The chest pain was associated with shortness of breath, diaphoresis, nausea, vomiting, and tachycardia. The patient's medical history was significant for multiple episodes of deep venous thrombosis (DVT) in the left upper extremity and both lower extremities, a right above-the-knee amputation due to complications of a previous DVT, insertion of a vena cava filter, pulmonary embolism (PE), asthma, hypertension, and multiple myocardial infarctions. During admission, he was diagnosed presumptively with PE. All potential causes of interference with warfarin absorption were investigated and ruled out. I.V. warfarin therapy at a conventional initial dosage of 5 mg once daily was started on hospital day 2. The International Normalized Ratio (INR) reached the therapeutic range after increasing the i.v. warfarin dosage to 7.5 mg once daily on hospital day 6. The ability to obtain a therapeutic INR on a relatively low dosage of i.v. warfarin but not high dosages of oral warfarin strongly suggests an inherent warfarin malabsorption defect in this patient.. A 42-year-old man with a history of recurrent thromboembolisms demonstrated resistance to oral warfarin therapy due to warfarin malabsorption.

    Topics: Adult; Anticoagulants; Chest Pain; Drug Resistance; Humans; Injections, Intravenous; International Normalized Ratio; Malabsorption Syndromes; Male; Obesity; Pulmonary Embolism; Venous Thrombosis; Warfarin

2009
Silent infection of Giardia lamblia causing bleeding through vitamin K malabsorption.
    Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:10

    Topics: Animals; Anticoagulants; Diagnosis, Differential; Female; Giardia lamblia; Giardiasis; Hemorrhage; Humans; Malabsorption Syndromes; Middle Aged; Vitamin K; Warfarin

2001
Vitamin K deficiency embryopathy: a phenocopy of the warfarin embryopathy due to a disorder of embryonic vitamin K metabolism.
    American journal of medical genetics, 1997, Oct-17, Volume: 72, Issue:2

    Three unrelated infants presented with radiographic punctate calcifications, nasal hypoplasia, and abnormalities of the spine. Additional anomalies included cupped ears in 2 patients and one each with Dandy-Walker malformation with hydrocephaly, congenital cataracts, and peripheral pulmonary artery stenosis. The mothers of these 3 patients had chronic conditions associated with intestinal malabsorption requiring total parenteral nutrition for varying periods of time. The underlying causes of malabsorption were celiac disease, short bowel syndrome secondary to surgical resection, and jejuno-ileal bypass, respectively. Bleeding diathesis occurred in one mother requiring vitamin K supplementation during the second and third trimesters of pregnancy. We speculate that the chondrodysplasia punctata and other abnormalities in these children were caused by an acquired maternal vitamin K deficiency manifested during early pregnancy. However, the involvement of other vitamin deficiencies cannot be excluded. Thus, vitamin K deficiency of the embryo secondary to maternal malabsorption appears to be a third vitamin K-related mechanism leading to chondrodysplasia punctata in addition to warfarin embryopathy and epoxide reductase deficiency (pseudo-warfarin embryopathy).

    Topics: Abnormalities, Drug-Induced; Anticoagulants; Child, Preschool; Chondrodysplasia Punctata; Female; Fetal Diseases; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Malabsorption Syndromes; Pregnancy; Pregnancy Complications; Radiography; Vitamin K; Vitamin K Deficiency; Warfarin

1997
Warfarin resistance in a patient with short-bowel syndrome.
    Nutrition reviews, 1987, Volume: 45, Issue:7

    Topics: Adult; Drug Resistance; Female; Humans; Malabsorption Syndromes; Short Bowel Syndrome; Warfarin

1987